RESONANCE SPECIALTIES
|
RESONANCE SPECIALTIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 4.33 | 10.71 | 9.12 | 4.77 | 2.78 |
| CEPS(Rs) | 5.61 | 12.22 | 9.97 | 5.57 | 3.56 |
| DPS(Rs) | 1.00 | 1.00 | 1.00 | 1.00 | - |
| Book NAV/Share(Rs) | 43.36 | 40.00 | 30.35 | 21.57 | 18.05 |
| Tax Rate(%) | 27.00 | 24.11 | 27.74 | 20.42 | 32.65 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 10.36 | 19.70 | 18.31 | 12.17 | 10.62 |
| EBIT Margin(%) | 10.57 | 19.23 | 19.08 | 11.41 | 11.65 |
| Pre Tax Margin(%) | 10.41 | 19.15 | 18.70 | 10.86 | 10.47 |
| PAT Margin (%) | 7.60 | 14.54 | 13.52 | 8.64 | 7.05 |
| Cash Profit Margin (%) | 9.84 | 16.59 | 14.78 | 10.08 | 9.05 |
| Performance Ratios | |||||
| ROA(%) | 8.16 | 22.19 | 21.98 | 13.89 | 8.54 |
| ROE(%) | 10.39 | 30.44 | 35.11 | 24.08 | 16.66 |
| ROCE(%) | 14.14 | 39.75 | 48.33 | 31.51 | 25.29 |
| Asset Turnover(x) | 1.07 | 1.53 | 1.63 | 1.61 | 1.21 |
| Sales/Fixed Asset(x) | 1.37 | 1.90 | 1.77 | 1.52 | 1.09 |
| Working Capital/Sales(x) | 1.73 | 2.22 | 3.04 | 4.21 | 3.70 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.73 | 0.53 | 0.56 | 0.66 | 0.91 |
| Receivable days | 56.93 | 37.82 | 36.46 | 39.24 | 57.12 |
| Inventory Days | 96.41 | 60.60 | 70.23 | 63.74 | 75.54 |
| Payable days | 84.83 | 72.52 | 107.26 | 116.55 | 130.07 |
| Valuation Parameters | |||||
| PER(x) | 17.90 | 16.47 | 13.76 | 5.29 | 7.31 |
| PCE(x) | 13.82 | 14.43 | 12.58 | 4.54 | 5.70 |
| Price/Book(x) | 1.79 | 4.41 | 4.13 | 1.17 | 1.12 |
| Yield(%) | 1.29 | 0.57 | 0.80 | 3.96 | - |
| EV/Net Sales(x) | 1.49 | 2.57 | 1.99 | 0.48 | 0.54 |
| EV/Core EBITDA(x) | 10.37 | 10.78 | 8.84 | 2.81 | 3.50 |
| EV/EBIT(x) | 12.57 | 11.93 | 9.42 | 3.73 | 4.11 |
| EV/CE(x) | 1.33 | 3.44 | 2.56 | 0.66 | 0.57 |
| M Cap / Sales | 1.52 | 2.69 | 2.06 | 0.52 | 0.58 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -22.36 | 7.78 | 25.21 | 39.43 | 11.96 |
| Core EBITDA Growth(%) | -53.40 | 14.26 | 64.07 | 55.28 | 235.33 |
| EBIT Growth(%) | -57.46 | 10.10 | 104.19 | 37.42 | 676.45 |
| PAT Growth(%) | -59.54 | 17.44 | 91.08 | 71.86 | 561.68 |
| EPS Growth(%) | -59.54 | 17.44 | 91.08 | 71.86 | 561.69 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.04 | - | 0.03 | 0.02 | - |
| Current Ratio(x) | 6.70 | 12.52 | 3.12 | 2.78 | 2.28 |
| Quick Ratio(x) | 3.23 | 9.02 | 1.75 | 1.21 | 1.35 |
| Interest Cover(x) | 65.09 | 238.42 | 51.15 | 20.53 | 9.88 |
| Total Debt/Mcap(x) | 0.02 | - | 0.01 | 0.02 | - |
Compare Financial Ratios of peers of RESONANCE SPECIALTIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RESONANCE SPECIALTIES | ₹126.7 Cr | -9.8% | 14% | 35.6% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹148,494.0 Cr | -1.1% | -4.1% | 15.7% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹80,170.6 Cr | -1.8% | 1.6% | 130% | Stock Analytics | |
| SRF | ₹67,494.5 Cr | -12.1% | -12.5% | -10% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹36,061.6 Cr | -10.3% | 0.8% | -5.5% | Stock Analytics | |
| DEEPAK NITRITE | ₹34,002.8 Cr | -2.7% | 13% | 25.6% | Stock Analytics | |
RESONANCE SPECIALTIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RESONANCE SPECIALTIES | -9.8% |
14% |
35.6% |
| SENSEX | -1.6% |
-2.1% |
19% |
You may also like the below Video Courses
